Skip to main content
Fig. 2 | EJNMMI Research

Fig. 2

From: 99mTc-labelled S-HYNIC certolizumab pegol in rheumatoid arthritis and spondyloarthritis patients: a biodistribution and dosimetry study

Fig. 2

a WB images immediately (left), 5 h (middle) and 24 h (right) pi of 706 MBq 99mTc-S-HYNIC CZP. b Static images (at 5 h pi) of the hands in a female suffering axial SpA. This patient presented with only radiographic axial involvement and had no signs of peripheral articular involvement. No enhanced tracer uptake in peripheral joints or the axial skeleton was noted

Back to article page